FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental pharmacology and urology, and concerns preventing ischemia-reperfusion renal injuries. For this purpose, Wistar rats 120 minutes before simulating renal ischemia by applying non-traumatic clamps on renal pedicles for 40 minutes followed by reperfusion of blood flow, arginase II KUD975 inhibitor 3 mg/kg is administered intragastrically through a probe.
EFFECT: method provides effective prevention of renal ischemia-reperfusion injury, including due to endothelium-protective properties of the preparation administered at the experimentally established time.
1 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING ISCHEMIA-REPERFUSION RENAL INJURIES WITH AN INHIBITOR OF ARGINASE II IN EXPERIMENT | 2018 |
|
RU2695333C1 |
METHOD FOR PREVENTING RENAL DYSFUNCTIONS WITH CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2018 |
|
RU2695334C1 |
METHOD FOR PREVENTING MICROCIRCULATION DISORDERS IN KIDNEYS WITH ASIALISED ERYTHROPOIETIN IN EXPERIMENT | 2018 |
|
RU2696864C1 |
METHOD FOR PREVENTING RENAL ISCHEMIA REPERFUSION INJURY BY CARBAMYLATED DARBEPOETIN IN EXPERIMENT | 2018 |
|
RU2678768C1 |
METHOD FOR CORRECTING MICROCIRCULATION DISORDERS IN KIDNEY WITH INFLIXIMAB IN ISCHEMIA-REPERFUSION INJURY | 2021 |
|
RU2753247C1 |
METHOD FOR CORRECTING MICROCIRCULATION DISORDERS IN KIDNEY WITH PEPTIDE THAT MIMICS ALPHA-HELIX B OF ERYTHROPOIETIN IN ISCHEMIA-REPERFUSION INJURY | 2021 |
|
RU2751413C1 |
METHOD OF AGENT APPLICATION BASED ON HUMAN MODIFIED PEROXYREDOXIN 2 FOR CORRECTING CONSEQUENCES OF ISCHEMIC-REPERFUSIVE KIDNEY DAMAGE | 2020 |
|
RU2747121C1 |
METHOD FOR CORRECTION OF ISCHEMIC DISORDERS CAUSED BY REPERFUSION LIVER INJURY | 2012 |
|
RU2479872C1 |
METHOD OF KIDNEY PREUNCONDITIONING IN CARDIOVASCULAR SURGERY | 2019 |
|
RU2712015C1 |
METHOD FOR PREVENTING AND TREATING ACUTE POSTISCHEMIC RENAL INSUFFICIENCY | 2020 |
|
RU2737802C2 |
Authors
Dates
2019-08-05—Published
2018-09-25—Filed